ACTRN12622001405707尚未招募2 期
Milrinone infusion for cerebral vasospasm in aneurysmal sub-arachnoid haemorrhage patients: a pilot randomised controlled study
Monash Medical Centre0 个研究点目标入组 40 人开始时间: 2022年11月2日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Admitted to ICU
- •Radiologically confirmed vasospam
排除标准
- •Whole territory cerebral infarction in the vasospasm territory on CT scan
- •Cardiac failure requiring inotropic support
- •Any contraindication to milrinone
研究者
相似试验
招募中
2 期
Effect of Milrinonein treatment vasospasm in patients with ?subarachnoid hemorrhagesubarachnoid hemorrhage.Nontraumatic subarachnoid hemorrhageIRCT20141209020258N82Arak University of Medical Sciences32
已完成
3 期
Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhageVasospasmNCT04362527University Hospital, Angers370
招募中
3 期
MIVAR - Milrinone Infusion for VAsospam treatment in subarachnoid
hemoRrhage2024-515994-83-00Centre Hospitalier Universitaire D'Angers370
已完成
2 期
Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination TherapyOral NimodipineMilrinoneVascular Spasm After Traumatic SubarachnoidhaemorrhageNCT05131867Zagazig University30
进行中（未招募）
不适用
Administration of the approved drug milrinone via venous access to treat and to prevent vasospasmSAB-induced vasospasmEUCTR2009-016620-32-ATDept. of Neurological Surgery, Medical University of Vienna